3M has settled with two companies it had accused of reselling N95 masks at inflated prices amid the COVID-19 pandemic.
Mylan has succeeded in having a key Biogen patent covering multiple sclerosis drug Tecfidera invalidated by a US federal court.
Roche Diabetes Care, a subsidiary of Switzerland-based Roche, has accused medical device company Insulet of infringing a patent covering a blood glucose level monitor.
The European Commission has backed voluntary IP licensing as part of its new vaccines strategy.
MicroPort Orthopedics has sued rival Medacta, accusing it of providing surgeons with “knock-off copies and defaced versions” of MicroPort’s patented surgical tools.
Switzerland-based Novartis has failed to convince the UK Intellectual Property Office that a trademark applied-for by Boston Healthcare should not be registered.
Genetic sequencing company Illumina has obtained a preliminary injunction against its China-based rival BGI.
The UK Intellectual Property Office has agreed to revoke an extension to a supplementary protection certificate for immunosuppressant tocilizumab, at the request of the owners.
The US Supreme Court has declined to review Eli Lilly’s patent infringement victory against Dr Reddy’s and Hospira.
Discussions around artificial intelligence (AI) and IP can sometimes be futuristic and trapped at the level of high-concept: whether machines can be inventors, for example. But at BIO Digital 2020, a panel of experts was on hand to provide a much more practical, down-to-earth guide to patenting AI inventions.